Helix Energy Slips To Loss In Q4

Helix Energy Solutions Group Inc. (HLX) reported a net loss of $13.7 million, or $0.09 per share, for the fourth quarter of 2018 compared to net income of $50.6 million, or $0.34 per share for the same period in 2017.

Net income in the fourth quarter of 2017 included a non-cash benefit of about $51.6 million or $0.35 per share, related to the U.S. tax law changes enacted in December 2017.

Net revenues declined to $158.36 million from $163.27 million last year.

Shares of Biogen Inc. are falling almost 28 percent in Thursday's trading after the company and Japanese drugmaker Eisai Co. said they will discontinue two late-stage trials for their experimental Alzheimer's drug, Aducanumab. The two Phase 3 trials, ENGAGE and EMERGE, are multi-center, randomized, double-blind, placebo-controlled, parallel-group studies designed to evaluate Aducanumab.

The European Union on Wednesday ordered Alphabet Inc.'s Google to pay an antitrust fine of 1.49 billion euros for abusing its dominant position in the online search advertising intermediation market by preventing competition. This is the third antitrust fine by the EU against Google and it represents 1.29 percent of the tech giant's turnover in 2018.

Shares of BMW Group declined around 5 percent in German trading after the auto giant reported Wednesday weak profit in its fiscal year 2018, despite a 0.1 percent growth in Automotive revenues with higher deliveries. Looking ahead for fiscal 2019, the company expects Group profit before tax will be well below the previous year's level. BMW said it is confident of volume growth in Automotive unit.